Figure 1
Relapse-free survival of 69 patients treated with paclitaxel/carboplatin for early-stage (FIGO stages I-IIb) ovarian carcinoma.
Figure 1 | BMC Cancer
Relapse-free survival of 69 patients treated with paclitaxel/carboplatin for early-stage (FIGO stages I-IIb) ovarian carcinoma.